Other ulcerative colitis

ULCEROTH

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K51.8 Cause of death: ICD-10 — K51.8 2 out of 7 registries used, show all original rules.	2342
4. Check minimum number of events None	2342
5. Include endpoints None	2342
6. Filter based on genotype QC (FinnGen only)	2342

Control definitions (FinnGen only)

Control exclude: K11_ENERCOLNONINF

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K51
Name in latin: Alia colitis ulcerosa specificata

NAME	ULCEROTH
CONTROL_EXCLUDE	K11_ENERCOLNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K518
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K518
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other ulcerative colitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	12782	6042	6700
Only index persons	12237	5850	6387
Unadjusted period prevalence (%)
Whole population	0.18	0.17	0.19
Only index persons	0.23	0.22	0.24
Median age at first event (years)
Whole population	43.13	41.97	44.08
Only index persons	42.48	41.50	43.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2342	1229	1113
Unadjusted period prevalence (%)	0.45	0.42	0.49
Median age at first event (years)	43.94	41.20	46.96

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2114: Matched controls
21138

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

+∞

323.0

707

A07EA02

ATC

hydrocortisone; rectal

365.4

323.0

769

K51.5

ICD-10 Finland

Left sided colitis

8596.3

323.0

1230

A07EC02

ATC

mesalazine; oral, rectal

1849.9

323.0

1842

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

1891

A07EA06

ATC

budesonide; oral, local oral

251.3

323.0

738

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2403.9

323.0

373

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6363.0

323.0

1329

K50.9

ICD-10 Finland

Crohn disease, unspecified

1249.5

323.0

319

UJF32

NOMESCO Finland

Coloscopy

31.3

323.0

1682

2335

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

14.7

323.0

622

581

UJF30

NOMESCO Finland

Ileoscopy through colon

21.3

323.0

858

656

K50.8

ICD-10 Finland

Other Crohn disease

+∞

323.0

402

L04AX01

ATC

azathioprine; systemic

95.9

323.0

1027

206

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

323.0

460

K51.8

ICD-10 Finland

Other ulcerative colitis

4503599627370496.0

323.0

2113

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

323.0

355

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

+∞

323.0

396

H02AB06

ATC

prednisolone; systemic

9.3

323.0

1689

6321

A07EC01

ATC

sulfasalazine; oral, rectal

12.1

306.6

609

686

K51

ICD-10 Finland

Ulcerative colitis

1696.5

305.7

290

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

53.6

292.4

350

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

738.0

269.2

260

H02AB07

ATC

prednisone; oral

7.1

244.5

691

1348

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.2

243.4

1001

3105

L01BB02

ATC

mercaptopurine; oral

231.7

242.3

246

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

240.3

226

K50.0

ICD-10 Finland

Crohn disease of small intestine

2104.5

212.0

202

J01MA02

ATC

ciprofloxacin; systemic

4.2

201.7

1161

4771

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

125.8

201.5

215

D94

ICPC

Chronic enteritis/ulcerative colitis

286.1

181.8

183

A07EA01

ATC

prednisolone; rectal

464.7

174.5

172

P01AB01

ATC

metronidazole; oral, rectal

3.7

168.5

1164

5300

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

+∞

166.9

158

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.0

159.9

848

3057

ZX120

NOMESCO Finland

Intravenous

6.5

154.9

445

829

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

+∞

141.2

134

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

130.6

124

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

+∞

128.5

122

K83.0

ICD-10 Finland

Cholangitis

32.1

126.7

169

TPH04

NOMESCO Finland

Cathetrisation of vein

3.8

125.1

656

2248

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

+∞

124.2

118

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

71.8

123.4

141

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

+∞

119.9

114

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

+∞

99.8

A05AA02

ATC

ursodeoxycholic acid; oral

16.3

98.6

163

108

L04AB04

ATC

adalimumab; parenteral

13.9

91.1

161

125

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

53.6

89.5

107

UJF92

NOMESCO Finland

Capsular endoscopy

14.0

86.6

152

116

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.2

86.3

533

1988

A06AC01

ATC

ispaghula (psylla seeds); oral

3.0

82.1

582

2378

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

10.6

78.7

158

160

A07DA03

ATC

loperamide; oral

8.6

76.6

174

219

WX302

NOMESCO Finland

Thoracal epidural anesthesy

6.2

73.1

208

364

A07EC03

ATC

olsalazine; oral

711.2

70.5

Z93.2

ICD-10 Finland

Ileostomy status

129.5

70.4

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

16.4

70.2

115

JFH10

NOMESCO Finland

Total colectomy and ileostomy

151.1

69.4

4AA12

NOMESCO Finland

149.0

68.4

4AB02

NOMESCO Finland

124.2

67.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

67.1

929

5390

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

46.7

66.3

C10AC01

ATC

colestyramine; oral

10.8

66.1

131

129

A02BC02

ATC

pantoprazole; systemic

2.2

60.8

1365

9677

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

604.7

60.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.7

58.2

283

855

H02AB09

ATC

hydrocortisone; systemic

9.0

56.4

123

144

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.3

56.4

320

1090

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.7

56.2

170

319

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.7

55.4

202

467

WX002

NOMESCO Finland

Sedation and analgesia

2.6

54.8

470

2086

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

53.1

305

1042

L04AD01

ATC

ciclosporin; systemic

9.2

52.6

113

129

K50

ICD-10 Finland

Crohn disease [regional enteritis]

266.9

51.3

JFF10

NOMESCO Finland

Loop enterostomy

29.2

50.3

K92.1

ICD-10 Finland

Melaena

5.4

50.0

157

308

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.4

49.2

267

874

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

+∞

48.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.3

46.4

115

165

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

10.0

46.0

L04AC05

ATC

ustekinumab; parenteral

85.4

45.0

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

+∞

43.9

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

10.4

43.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

43.0

793

4923

JFH11

NOMESCO Finland

Laparoscopic colectomy

+∞

42.8

UJG02

NOMESCO Finland

Proctoscopy

8.7

42.2

111

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

41.8

1370

FHL

Colonoscopy, whole colon

40.2

40.7

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

11.1

38.5

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

46.9

37.9

4AA33

NOMESCO Finland

+∞

37.6

L04AA01

ATC

[U] ciclosporin; systemic

9.6

37.6

JF1BD

NOMESCO Finland

Very extensive small bowel CT

25.3

37.2

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.2

36.3

144

360

JAH00

NOMESCO Finland

Laparotomy

6.6

35.8

147

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

32.0

35.8

UJK02

NOMESCO Finland

ERCP

7.0

35.7

133

N02AX02

ATC

tramadol; systemic, rectal

1.8

35.5

837

5572

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

35.3

476

2568

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.8

35.2

139

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.2

35.2

162

A07AA09

ATC

vancomycin; oral

13.3

34.7

253

Kela drug reimbursment

+∞

34.5

3042

Kela drug reimbursment

+∞

34.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

34.4

317

1430

K56.7

ICD-10 Finland

Ileus, unspecified

10.0

34.1

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.5

34.1

113

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.7

33.9

120

268

6419

FHL

Other measure in this category

177.8

33.8

L04AB06

ATC

golimumab; parenteral

11.6

33.6

K51.4

ICD-10 Finland

Inflammatory polyps

+∞

33.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.2

33.2

184

607

A02BC01

ATC

omeprazole; systemic

2.0

32.7

544

3177

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

32.3

147

415

Z93

ICD-10 Finland

Artificial opening status

62.7

32.1

JFF13

NOMESCO Finland

Terminal enterostomy

53.7

31.3

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

+∞

31.3

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

31.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

30.3

246

1033

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

18.8

30.1

UJK12

NOMESCO Finland

Peroral cholangioscopy

69.0

29.9

A02BC03

ATC

lansoprazole; oral

1.9

29.9

568

3463

JHA00

NOMESCO Finland

Anal or perianal incision

7.7

29.9

K59.1

ICD-10 Finland

Functional diarrhoea

3.9

29.6

127

341

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

4.4

29.3

110

261

C05AA08

ATC

fluocortolone; rectal, topical

2.3

29.3

308

1475

B01AB05

ATC

enoxaparin; parenteral

1.9

28.5

560

3446

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

36.6

28.4

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

+∞

28.2

N02BE01

ATC

paracetamol; systemic, rectal

1.8

28.2

1722

14876

R50.9

ICD-10 Finland

Fever, unspecified

2.2

28.0

317

1567

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

27.5

182

676

3AC01

NOMESCO Finland

8.8

27.3

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

11.3

27.1

JFB00

NOMESCO Finland

Partial resection of small intestine

8.5

26.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.1

26.7

174

J01MA12

ATC

levofloxacin; systemic

2.0

26.1

360

1933

TJF80

NOMESCO Finland

Ostomy education

9.7

26.0

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

263.7

25.7

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

7.8

25.3

WX402

NOMESCO Finland

General anaesthesia

2.0

25.0

365

2002

WVA20

NOMESCO Finland

Medicine administration

5.4

24.9

145

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

24.8

291

1456

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

8.3

24.7

M45

ICD-10 Finland

Ankylosing spondylitis

5.0

24.6

164

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

24.6

264

1272

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

11.8

24.5

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.2

24.4

UJF02

NOMESCO Finland

Peroral enteroscopy

18.8

24.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

24.3

191

785

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

24.0

SPAT1263

SPAT

Sampling

1.6

23.6

837

6070

K61.0

ICD-10 Finland

Anal abscess

5.5

23.5

130

H02AB04

ATC

methylprednisolone; systemic

2.1

23.4

294

1517

SPAT1262

SPAT

Handing over of treatment supplies

2.0

22.9

344

1900

K60.3

ICD-10 Finland

Anal fistula

4.9

22.9

160

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.3

22.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

22.8

138

484

M05BA04

ATC

alendronic acid; oral

3.0

22.8

136

472

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

40.5

22.7

3005

Kela drug reimbursment

Tofacitinib

35.4

22.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

21.8

182

772

1490

FHL

Sigmoideoscopy (fiberscope)

39.1

21.7

K56.0

ICD-10 Finland

Paralytic ileus

11.6

21.7

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.1

21.3

210

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

20.8

536

3533

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.3

20.8

212

992

A02BC05

ATC

esomeprazole; systemic

1.6

20.6

750

5419

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.6

20.3

157

636

UJD02

NOMESCO Finland

Gastroscopy

3.3

20.2

106

337

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

+∞

19.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

19.7

770

5648

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

13.3

19.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.2

19.6

106

344

JF2AB

NOMESCO Finland

Colongraphy with X-ray

40.5

19.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

19.3

187

853

JJC00

NOMESCO Finland

Allogenic transplantation of liver

26.3

19.1

JHD00

NOMESCO Finland

Anal dilatation

9.9

19.1

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

+∞

18.8

6410

FHL

Panprococolectomy and ileostomy

+∞

18.8

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.5

18.7

156

659

UJF34

NOMESCO Finland

Left colonoscopy

10.4

18.6

Z94.4

ICD-10 Finland

Liver transplant status

16.3

18.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

18.3

143

586

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

13.7

18.2

L04AA29

ATC

tofacitinib; oral

26.9

17.8

1380

FHL

Colonoscopy, left side

+∞

17.7

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

+∞

17.7

L04AA33

ATC

vedolizumab; parenteral

+∞

17.7

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.1

17.5

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.8

17.0

109

397

J01DB01

ATC

cefalexin; oral

1.6

16.9

1653

14693

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.1

16.8

324

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

7.5

16.7

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

+∞

16.7

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

+∞

16.7

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

+∞

16.7

D16

ICPC

Rectal bleeding

4.5

16.6

135

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

27.8

16.5

E86

ICD-10 Finland

Volume depletion

5.0

16.2

107

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

16.1

717

5359

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

16.1

391

2509

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

24.7

16.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

15.9

882

6902

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.2

15.9

150

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

15.7

101

369

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

+∞

15.6

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

19.4

15.5

JF1AD

NOMESCO Finland

Small bowel CT

13.8

15.5

A02BA02

ATC

ranitidine; systemic

1.7

15.1

316

1939

ZXD05

NOMESCO Finland

Urgent procedure

1.5

15.0

587

4247

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

15.0

177

886

SPAT1255

SPAT

Intravenous administration of medicine

2.4

14.9

128

552

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

5.7

14.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

14.8

253

1455

K60.4

ICD-10 Finland

Rectal fistula

31.9

14.8

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

16.6

14.8

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

14.7

128

554

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

18.5

14.7

J02AC01

ATC

fluconazole; systemic

1.5

14.5

731

5576

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

12.6

14.4

D11

ICPC

Diarrhoea

1.9

14.3

234

1324

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

14.1

104

415

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

14.5

14.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

13.9

358

2326

UJH02

NOMESCO Finland

Anoscopy

2.8

13.9

314

Z3231

NOMESCO Finland

Registered nurse

1.5

13.8

484

3403

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

13.7

194

1041

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

13.7

165

832

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

13.7

154

755

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

13.6

181

951

Z43.2

ICD-10 Finland

Attention to ileostomy

34.2

13.5

5604

FHL

Vascular preparation or cannulation in the operating room

25.9

13.4

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.8

13.4

SPAT1125

SPAT

Stoma care and guidance

6.2

13.3

J01DA01

ATC

[U] cefalexin; systemic

1.4

13.3

1197

10151

E0000UV

ATC

1.4

13.2

724

5592

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.1

13.2

128

B80

ICPC

Iron deficiency anaemia

4.0

12.9

126

WW200

NOMESCO Finland

Immunization

3.1

12.6

223

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

5.1

12.6

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

+∞

12.5

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

+∞

12.5

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

12.5

372

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.3

12.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

12.5

317

2052

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

20.2

12.5

B01AB10

ATC

tinzaparin; parenteral

2.3

12.4

119

542

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

13.2

12.4

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

12.4

110

482

R4190

NOMESCO Finland

Nutritional therapy

2.9

12.3

271

ZXC86

NOMESCO Finland

Use of endoscopic device

8.0

12.3

K76.9

ICD-10 Finland

Liver disease, unspecified

5.1

12.3

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

37.8

12.2

M81.4

ICD-10 Finland

Drug-induced osteoporosis

12.5

12.1

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

12.0

336

D99

ICPC

Disease digestive system other

5.8

11.9

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.6

11.9

357

D18

ICPC

Change in faeces/bowel movements

3.9

11.9

126

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

7.1

11.8

JFA70

NOMESCO Finland

Suture of small intestine

14.7

11.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

11.6

281

K62.4

ICD-10 Finland

Stenosis of anus and rectum

23.0

11.6

K74.3

ICD-10 Finland

Primary biliary cirrhosis

8.7

11.5

JFG96

NOMESCO Finland

Other operation on intestinal stoma or pouch

+∞

11.5

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

11.5

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

13.7

11.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

11.4

216

1283

A07AA02

ATC

nystatin; oral

2.2

11.3

109

499

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

15.1

11.3

WX892

NOMESCO Finland

Monitored bed care

2.1

11.3

130

645

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.0

11.2

108

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

11.2

756

6027

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

20.1

11.1

127

Kela drug reimbursment

Transplant complication

4.2

11.0

100

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

11.0

222

WZC30

NOMESCO Finland

Teaching

1.7

10.9

221

1338

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

10.8

129

647

WW500

NOMESCO Finland

Blood transfusion

2.7

10.8

284

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

10.8

201

1185

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

10.8

111

525

D07AC01

ATC

betamethasone; topical

1.4

10.8

590

4519

R53

ICD-10 Finland

Malaise and fatigue

1.6

10.7

334

2271

6525

FHL

Enterostomy occlusion

28.2

10.7

N03AX16

ATC

pregabalin; oral

1.5

10.7

385

2707

JFA76

NOMESCO Finland

Closure of fistula of small intestine

60.3

10.6

Z93.3

ICD-10 Finland

Colostomy status

7.3

10.5

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.3

10.4

157

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

110.5

10.4

6408

FHL

Colectomy and ileostomy

+∞

10.4

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

+∞

10.4

K65.0

ICD-10 Finland

Acute peritonitis

5.6

10.4

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

10.4

126

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

10.4

201

1202

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

10.3

491

3660

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

18.9

10.3

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.1

10.0

SPAT1153

SPAT

Removal of sutures

1.4

10.0

503

3785

K91.8

ICD-10 Finland

Other postprocedural disorders of digestive system, not elsewhere classified

40.3

10.0

D06BX01

ATC

metronidazole; topical

1.8

9.9

184

1087

WX704

NOMESCO Finland

Intubation

2.0

9.8

123

632

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

4.8

9.6

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

7.8

9.6

E000001

ATC

1.5

9.6

368

2616

UKC02

NOMESCO Finland

Cystoscopy

1.7

9.6

224

1415

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.1

9.5

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

15.1

9.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

9.5

251

1637

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

100.5

9.4

JFH01

NOMESCO Finland

Laparoscopic colectomy with ileorectal anastomosis

+∞

9.4

5589X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis

+∞

9.4

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

+∞

9.4

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

+∞

9.4

K61.1

ICD-10 Finland

Rectal abscess

9.5

9.3

JHD20

NOMESCO Finland

Incision of fistula-in-ano

4.4

9.2

Z2221

NOMESCO Finland

Medical doctor

1.4

9.2

488

3699

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

5.7

9.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

9.2

274

1843

ZXE00

NOMESCO Finland

One hour or less

1.4

9.1

706

5706

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

7.8

9.1

K83.1

ICD-10 Finland

Obstruction of bile duct

4.6

9.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

9.0

352

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

9.1

9.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

9.0

643

5130

Z50.1

ICD-10 Finland

Other physical therapy

2.1

8.9

457

C05AA01

ATC

hydrocortisone; rectal, topical

2.2

8.9

389

XQ802

NOMESCO Finland

Epicutan test

2.3

8.9

349

A02BA04

ATC

nizatidine; systemic

2.0

8.8

118

620

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

8.8

120

638

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

8.8

309

2158

D07AD01

ATC

clobetasol; topical

1.6

8.7

252

1680

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

8.7

578

4547

JFB30

NOMESCO Finland

Right hemicolectomy

4.9

8.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

8.7

193

1202

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.7

693

5625

M25.5

ICD-10 Finland

Pain in joint

1.4

8.6

485

3712

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

8.6

404

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

8.6

533

4148

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

11.6

8.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

8.5

108

559

K63.9

ICD-10 Finland

Disease of intestine, unspecified

9.0

8.5

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

90.4

8.4

N02AA05

ATC

oxycodone; systemic

1.7

8.4

195

1226

L88

ICD-10 Finland

Pyoderma gangrenosum

12.8

8.4

SPAT1104

SPAT

Monitoring of emergency patient

2.0

8.3

108

562

4AC05

NOMESCO Finland

+∞

8.3

JFG70

NOMESCO Finland

Conversion of continent ileostomy to conventional ileostomy

+∞

8.3

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.7

8.3

197

D01

ICPC

Abdominal pain/cramps general

1.7

8.3

189

1184

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.3

8.2

119

WX720

NOMESCO Finland

Own respiration

2.3

8.2

305

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.2

1262

11222

J01MA01

ATC

ofloxacin; systemic

1.8

8.2

134

758

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

8.2

405

SPAT1260

SPAT

Consultation of another employee

1.5

8.2

287

1997

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

8.2

1611

17232

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

8.2

439

3329

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

8.2

288

2009

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

8.1

373

2745

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.5

8.1

244

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

33.5

8.1

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

6.8

8.1

B01AA03

ATC

warfarin; systemic

1.6

8.0

240

1612

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

10.1

8.0

A06AC51

ATC

ispaghula, combinations; systemic

2.1

7.9

396

S18

ICPC

Laceration/cut

1.3

7.9

660

5370

K85

ICD-10 Finland

Acute pancreatitis

3.3

7.9

112

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.2

7.9

123

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

7.9

117

644

R06.0

ICD-10 Finland

Dyspnoea

1.4

7.9

361

2654

B07.9

ICD-10 Finland

Verruca simplex

2.4

7.9

271

N05CF01

ATC

zopiclone; oral

1.4

7.8

484

3761

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.8

125

704

SPAT1254

SPAT

Administration of medicine

1.6

7.8

215

1419

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

7.8

315

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

15.1

7.7

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

7.7

220

E000003

ATC

2.1

7.7

424

JKA20

NOMESCO Finland

Cholecystectomy

2.8

7.7

166

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.7

7.6

J01FA10

ATC

azithromycin; systemic

1.3

7.6

1113

9780

L04AA06

ATC

mycophenolic acid; systemic

3.1

7.6

127

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

18.4

7.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

7.6

182

1157

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

25.1

7.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

7.6

104

555

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.9

7.5

155

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

7.5

215

1427

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.1

7.5

128

C10AC02

ATC

colestipol; oral

10.1

7.5

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

7.5

228

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.0

7.5

435

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

7.5

275

1934

A01AB09

ATC

miconazole; local oral

1.7

7.5

137

806

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.7

7.4

180

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

7.4

152

926

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.7

7.4

JG1JB

NOMESCO Finland

Defekography with X-ray

6.0

7.4

ZX100

NOMESCO Finland

Oral

3.9

7.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

7.3

482

3775

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

7.3

114

638

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

7.3

153

D07AC13

ATC

mometasone; topical

1.4

7.3

485

3804

JGB61

NOMESCO Finland

Laparoscopic excision of rectum and ileoanal anastomosis

+∞

7.3

6437

FHL

Rectum resection and sphincter-sparing through-anastomosis

+∞

7.3

WX110

NOMESCO Finland

Local anesthesy

1.3

7.3

1327

11971

R10.0

ICD-10 Finland

Acute abdomen

2.4

7.3

256

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

7.2

122

700

JAD10

NOMESCO Finland

Repair of incisional hernia

5.8

7.2

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

7.2

220

1488

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

7.2

114

640

JGB96

NOMESCO Finland

Other proctectomy or excision of rectum

30.1

7.1

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.8

7.1

JJ5AT

NOMESCO Finland

20.1

7.1

A10AE05

ATC

insulin detemir; parenteral

1.9

7.0

516

SPAT1325

SPAT

Vaccination

1.3

7.0

505

4009

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

3.3

6.9

J05AB01

ATC

aciclovir; systemic

1.4

6.9

343

2554

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

6.9

214

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

6.8

1001

8750

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

9.3

6.8

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.8

279

2008

B02.9

ICD-10 Finland

Zoster without complication

2.0

6.7

398

J01MA14

ATC

moxifloxacin; systemic

1.7

6.7

140

858

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

6.7

586

4780

JAH01

NOMESCO Finland

Laparoscopy

2.0

6.7

414

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.1

6.7

SPAT1312

SPAT

General health counselling

1.3

6.7

554

4488

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

6.4

6.6

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

6.6

115

670

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

6.6

258

1840

J01FF01

ATC

clindamycin; systemic

1.3

6.6

441

3460

ZX121

NOMESCO Finland

Central venous catheter

8.7

6.5

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

6.5

427

K90.0

ICD-10 Finland

Coeliac disease

2.4

6.5

228

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.1

6.5

L88

ICPC

Rheumatoid/seropositive arthritis

2.3

6.5

260

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

6.5

222

1537

J01FA06

ATC

roxithromycin; oral

1.3

6.5

687

5752

A12BA01

ATC

potassium chloride; oral

2.4

6.5

210

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.2

6.5

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

6.5

241

R01AD08

ATC

fluticasone; nasal

1.3

6.5

498

3989

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

6.4

143

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.2

6.4

262

N82.4

ICD-10 Finland

Other female intestinal-genital tract fistulae

70.1

6.4

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.9

6.4

435

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

6.4

161

1039

M02AA07

ATC

piroxicam; topical

1.3

6.4

531

4297

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

14.3

6.4

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

14.3

6.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

6.3

295

2173

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

6.3

143

897

WX004

NOMESCO Finland

Patient-controlled sedation

6.0

6.3

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

11.0

6.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.3

155

995

A07AA11

ATC

rifaximin; oral

9.3

6.3

C03CA01

ATC

furosemide; systemic

1.4

6.3

317

2370

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

6.2

167

1095

TGC00

NOMESCO Finland

Bronchial lavation

2.5

6.2

175

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.7

6.1

119

714

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

12.5

6.1

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

12.5

6.1

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

3.9

6.1

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

3.9

6.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

6.1

165

1085

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

6.1

217

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

6.1

154

JJA20

NOMESCO Finland

Open biopsy of liver

8.6

6.1

H25.8

ICD-10 Finland

Other senile cataract

1.8

6.0

105

612

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

6.0

199

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

1879

9153

6.33

321.03

14.9

5.6

e9/l

0.0

2.57

1777

7970

(3001604) Monocytes [#/volume] in Blood

1875

9125

6.29

320.47

14.8

5.6

e9/l

0.6

0.70

1772

7949

(3013115) Eosinophils [#/volume] in Blood

1903

9494

6.36

312.04

15.1

5.9

e9/l

0.2

0.00

1795

8411

(3017181) Myelocytes/100 leukocytes in Blood

659

1406

6.13

308.24

6.9

4.1

0.7

0.8

0.32

179

389

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

281

187.69

307.65

3.6

2.5

mg/l

8.0

6.0

0.93

238

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

512

510

12.57

307.65

1.7

1.5

iu/ml

10.8

0.1

0.59

117

(42870588) Differential panel, method unspecified - Blood

1502

5942

5.26

307.65

12.1

5.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1699

7128

6.04

307.65

4.2

2.1

nmol/l

73.8

74.8

0.82

1644

6498

(3048689) Calprotectin [Mass/mass] in Stool

1789

1954

35.54

307.65

7.7

1.3

ug/g

244.0

87.6

38.98

1707

1487

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

256

159.55

307.65

3.0

2.5

au/ml

71.3

252.0

—

(3022145) Colonoscopy Study observation

1343

1617

18.13

307.65

2.4

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1863

6963

9.19

307.65

11.7

4.5

g/l

36.3

36.2

0.75

1819

6490

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

803

963

12.17

307.65

2.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

626

1279

6.32

306.39

6.3

3.9

0.4

0.7

2.21

136

285

(3019198) Lymphocytes [#/volume] in Blood

1889

9453

6.16

305.93

14.9

5.6

e9/l

1.8

2.0

2.92

1801

8409

(3022096) Basophils/100 leukocytes in Blood

1755

8293

5.45

304.91

14.8

5.8

0.7

7.92

1691

7767

(3006504) Eosinophils/100 leukocytes in Blood

1778

8559

5.47

299.62

14.8

5.7

2.8

0.12

1711

7997

(3019069) Monocytes/100 leukocytes in Blood

1784

8616

5.49

299.23

15.2

6.0

8.8

8.5

4.80

1720

8101

(3025159) Blasts/100 leukocytes in Blood

614

1264

6.23

297.52

7.1

4.2

0.0

0.6

0.92

142

305

(3018010) Neutrophils/100 leukocytes in Blood

1790

8802

5.39

289.49

14.1

5.6

57.4

56.7

1.92

1728

8274

(3021440) Promyelocytes/100 leukocytes in Blood

622

1339

5.96

286.56

7.2

4.2

0.1

1.21

167

358

(3002030) Lymphocytes/100 leukocytes in Blood

1799

8928

5.38

286.15

15.0

5.7

28.3

28.6

0.92

1736

8367

(3013650) Neutrophils [#/volume] in Blood by Automated count

1932

10566

5.73

259.91

17.2

8.8

e9/l

4.0

4.1

1.60

1838

9264

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2207

13759

11.48

248.36

19.9

6.8

u/l

77.7

76.1

0.94

2161

12967

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1090

4086

4.12

245.00

4.2

2.0

mg/l

3.1

2.9

3.13

1009

3487

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

298

361

9.31

232.59

4.0

6.8

iu/ml

792.9

400.5

0.68

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

135

43.35

225.39

2.5

1.3

mg/l

9.5

8.8

0.27

112

(40760892) CBC W Ordered Manual Differential panel - Blood

1060

4338

3.64

200.79

11.6

4.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

293

491

6.68

170.71

2.1

1.2

titre

81.3

100.4

0.55

(3013707) Erythrocyte sedimentation rate by Westergren method

2024

13511

4.67

160.70

8.5

3.7

mm/h

12.7

10.4

11.62

1914

12602

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

642

2149

3.74

160.29

3.1

2.5

20.6

24.3

8.18

549

1850

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

148

11.61

152.41

2.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

408

1020

4.63

151.72

1.6

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

222

323

7.49

147.14

5.7

3.4

57.9

56.4

0.82

222

323

(3030905) Polymorphonuclear cells [#/volume] in Blood

218

311

7.63

147.05

5.6

3.1

e9/l

4.0

4.1

0.47

218

311

(3022948) Iron [Moles/volume] in Serum or Plasma

688

2543

3.41

145.69

3.1

2.4

umol/l

12.2

14.0

8.51

671

2355

(3004789) Transferrin [Mass/volume] in Serum or Plasma

652

2331

3.49

145.60

3.1

2.4

g/l

2.4

3.28

632

2165

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1213

6270

2.94

141.68

6.0

3.2

u/l

30.9

34.6

0.74

1140

5986

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1099

5470

2.90

136.42

4.8

2.5

u/l

62.4

56.4

1.91

1054

5068

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1524

9050

2.96

134.72

9.8

6.0

umol/l

10.3

11.4

4.15

1476

8591

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

208

320

7.04

130.73

1.6

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1415

8191

2.84

129.25

18.6

8.7

e9/l

0.0

1.01

1310

6703

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

118

+∞

124.07

3.1

0.0

mg/l

22.4

—

113

(3028026) IgM [Mass/volume] in Serum or Plasma

384

1062

4.13

123.77

2.2

1.8

g/l

1.3

1.4

0.55

362

978

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

116

+∞

121.95

3.1

0.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

658

2602

3.13

121.81

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

440

1378

3.70

118.40

3.0

2.6

g/l

11.8

10.5

6.93

415

1262

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

213

375

6.15

117.14

1.5

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

457

1530

3.47

110.49

4.1

2.2

g/l

0.2

1.89

432

1424

(3024980) IgG subclass 4 [Mass/volume] in Serum

179

286

6.69

108.23

2.5

1.6

g/l

0.9

0.02

150

215

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1385

8385

2.60

108.16

4.5

2.7

ug/l

108.8

116.5

0.36

1325

7855

(3032080) INR in Blood by Coagulation assay

1156

6534

2.52

102.89

10.6

7.8

inr

1.1

1.2

2.20

428

2015

(3037522) Nuclear Ab [Titer] in Serum

610

2604

2.82

95.47

1.8

1.3

titre

528.0

488.3

0.22

184

504

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

112

119

9.83

95.42

2.6

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

230

524

4.76

94.41

5.7

3.4

u/ml

65.9

2796.9

0.81

210

447

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

116

135

8.99

92.21

1.6

1.1

titre

360.4

150.5

1.59

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

116

135

8.99

92.21

1.6

1.1

titre

245.0

314.0

—

(3023368) Bacteria identified in Blood by Culture

835

4314

2.45

87.02

5.3

4.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

744

3647

2.52

86.91

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

235

591

4.31

84.90

2.2

1.5

titre

386.1

281.4

0.20

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

196

436

4.81

82.60

2.0

1.2

iu/ml

4.4

6.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1283

8233

2.23

77.66

8.7

6.6

mmol/l

1.2

0.34

1092

6995

(3009445) Proteinase 3 Ab [Units/volume] in Serum

255

728

3.81

77.15

1.9

1.5

u/ml

4.8

27.5

1.29

(40768441) Liver Pathology biopsy report

123

8.27

73.22

1.8

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

182

424

4.57

72.31

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2263

19253

6.20

70.96

31.3

11.8

mg/l

16.3

22.7

29.89

2072

14906

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

174

405

4.56

69.16

1.4

1.3

u/ml

278.4

256.3

0.34

254

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

131

241

5.70

68.33

4.1

2.8

u/ml

6.1

75.1

0.68

131

220

(3019309) Folate [Moles/volume] in Red Blood Cells

560

2680

2.43

66.46

2.1

1.7

nmol/l

1170.0

1179.4

0.07

428

2084

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

652

3404

2.27

62.80

2.3

1.6

pmol/l

18664818.0

43763417.8

0.59

584

2886

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

36.04

62.03

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

207

600

3.69

60.90

1.9

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1461

10431

2.07

60.39

6.3

4.7

mmol/l

6.6

0.01

1375

9681

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

106

180

6.12

60.03

1.8

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1039

6600

2.03

59.19

2.1

1.8

pmol/l

97.0

96.6

0.09

662

3555

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

106

184

5.99

58.70

1.8

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

120

239

5.24

57.31

1.4

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1659

12532

2.11

57.25

5.5

3.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

120

240

5.22

57.04

3.2

3.5

1.4

1.7

0.31

205

(3025468) Yersinia sp identified in Specimen by Organism specific culture

103

179

5.97

56.96

1.8

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

104

184

5.87

56.46

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

103

181

5.91

56.31

1.8

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

103

181

5.91

56.31

1.8

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

355

1477

2.65

55.85

5.9

4.2

ug/l

6.3

24.0

1.80

285

1195

(1761482) Bacteria [#/volume] in Urine by Culture

148

359

4.33

55.66

4.7

4.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

221

713

3.32

54.96

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

1094

7264

1.95

53.10

2.8

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

831

5066

1.99

51.37

4.5

2.9

—

(3010375) cycloSPORINE [Mass/volume] in Blood

8.23

48.77

25.1

27.0

ug/l

128.0

125.1

0.09

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

150

5.99

48.48

1.7

1.5

umol/l

11.2

11.7

0.31

140

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1045

6998

1.89

47.89

4.7

3.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1095

7458

1.88

47.46

7.3

5.9

mmol/l

1.2

0.00

1022

6796

(3042936) Bacteria identified in Isolate by Culture

483

2481

2.19

46.73

2.4

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

666

3861

2.01

46.67

2.0

1.4

g/l

2.5

2.3

1.95

513

2456

(3026782) Osmolality of Urine

595

3328

2.06

45.96

3.3

2.6

mosm/kgh2o

558.5

554.5

0.14

542

2831

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

122

300

4.24

45.00

5.7

3.8

u/ml

23.5

1292.2

0.87

112

281

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

153

5.66

44.20

1.3

1.2

u/l

77.0

57.4

0.61

106

(3014576) Chloride [Moles/volume] in Serum or Plasma

413

2036

2.25

43.99

9.8

7.4

mmol/l

104.8

104.4

1.31

408

1991

(3036481) Cortisol [Moles/volume] in Serum or Plasma

372

1760

2.32

43.66

2.6

2.2

nmol/l

325.8

374.0

5.00

352

1633

(3027273) Bicarbonate [Moles/volume] in Venous blood

200

701

3.03

43.03

5.7

3.4

mmol/l

25.0

25.2

0.34

194

678

(3002032) Base excess in Venous blood by calculation

323

1452

2.42

42.52

6.0

3.8

mmol/l

1.8

2.0

0.32

261

1159

(46235355) HIV 1 and 2 tests - Meaningful Use set

740

4572

1.90

42.26

1.8

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

1237

8959

1.81

42.12

4.4

3.3

estimate

0.0

0.80

330

1637

(3021447) Carbon dioxide [Partial pressure] in Venous blood

323

1459

2.41

42.04

6.0

3.8

kpa

5.8

5.9

0.40

315

1414

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

108

256

4.37

41.77

1.2

1.1

g/l

1.5

0.56

228

(3009261) Glucose [Presence] in Urine by Test strip

1244

9067

1.79

41.05

4.6

3.3

estimate

0.0

0.80

338

1603

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

398

1986

2.21

40.92

5.5

2.7

umol/l

6.5

7.9

1.30

362

1727

(3033705) Calcium.ionized [Moles/volume] in Venous blood

158

5.34

40.59

2.9

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1231

8980

1.78

40.16

6.3

4.5

estimate

0.0

0.50

345

1682

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2079

17973

2.40

39.85

23.7

10.7

ml/min/173m2

87.9

87.3

0.62

1879

14758

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2263

20465

4.14

39.05

31.7

13.4

umol/l

78.9

75.6

3.82

2263

20458

(3007930) Methemoglobin/Hemoglobin.total in Blood

180

629

3.02

38.86

4.8

5.1

1.0

0.9

1.80

175

587

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

178

632

2.97

37.34

4.8

5.1

1.6

1.7

0.61

173

590

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2266

20583

4.11

37.28

25.2

9.0

u/l

27.8

0.02

2245

19948

(40761536) Microorganisms panel - Urine sediment

321

1529

2.27

36.71

4.4

3.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

270

4.02

36.45

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

342

1679

2.21

36.32

3.6

2.4

u/l

45.1

67.6

0.36

318

1434

(3002385) Erythrocyte distribution width [Ratio]

1928

16392

2.00

35.29

32.5

14.5

13.8

13.5

13.91

1920

16048

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1170

8620

1.71

35.01

5.6

3.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

108

294

3.80

34.62

1.1

—

(40768797) Stomach Pathology biopsy report

431

2368

2.01

33.83

1.3

1.2

—

(3013512) EKG study

715

4634

1.78

33.48

4.1

3.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

206

837

2.60

33.35

3.3

2.7

e6/l

0.4

0.2

0.96

201

811

(3024354) Oxygen [Partial pressure] in Venous blood

263

1200

2.34

33.12

5.2

3.1

kpa

4.5

4.7

1.04

256

1158

(3000330) Specific gravity of Urine by Test strip

192

760

2.66

32.75

4.9

3.2

—

(40758558) Short blood count panel - Blood

705

4597

1.76

32.07

11.5

6.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2149

19228

2.43

31.56

24.1

13.3

mmol/l

139.3

139.7

12.30

2112

18735

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.50

31.43

1.9

2.4

u/ml

9705.3

34353.1

—

(3015736) pH of Urine

967

6906

1.68

31.40

3.8

3.1

—

5.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

118

5.37

31.12

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

118

5.37

31.12

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

219

946

2.45

31.12

5.2

3.1

g/l

129.6

131.3

0.50

209

922

(3021960) Folate [Moles/volume] in Serum or Plasma

580

3613

1.80

30.60

1.6

1.5

nmol/l

19.8

20.4

0.43

521

3143

(3023103) Potassium [Moles/volume] in Serum or Plasma

2151

19304

2.40

30.48

24.2

13.4

mmol/l

3.9

4.0

7.13

2111

18774

(3014765) Yersinia sp identified in Stool by Organism specific culture

144

511

2.94

30.18

1.5

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

823

5680

1.69

30.08

3.3

2.3

—

(3026008) Bacteria identified in Urine by Culture

701

4636

1.73

29.95

3.3

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

143

508

2.93

29.91

1.5

1.1

—

(3018418) pH of Serum or Plasma

724

4834

1.72

29.87

4.5

3.9

7.4

0.23

170

942

(42529406) Shigella sp [Presence] in Stool by Culture

144

516

2.91

29.65

1.5

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

127

424

3.11

29.61

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

6.04

29.06

1.4

1.1

u/l

100.5

75.5

0.97

(3006922) Hepatitis E virus Ab [Presence] in Serum

127

4.99

28.66

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.41

27.83

1.5

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

759

5224

1.67

27.48

3.8

3.0

e6/l

87.2

86.5

0.00

653

3971

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.32

27.46

1.5

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

118

395

3.09

27.39

1.4

1.5

u/ml

122.6

120.2

0.04

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

5.58

27.29

1.7

1.5

u/l

6.6

7.7

0.14

(3017732) Neutrophils [#/volume] in Blood

258

1272

2.16

26.74

3.6

2.8

e9/l

4.3

4.1

0.64

194

1048

(3027945) Reticulocytes/100 erythrocytes in Blood

314

1669

2.02

26.62

3.7

2.8

1.9

1.8

0.82

285

1501

(3029937) Albumin [Presence] in Urine by Test strip

697

4733

1.67

26.37

4.7

3.6

estimate

0.0

1.28

333

1621

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

4.97

26.30

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

118

4.93

26.04

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

5.74

26.03

1.4

1.1

u/l

42.5

16.4

0.84

(4062490)

189

4.01

25.95

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

3.32

25.80

2.9

3.0

u/ml

160.0

1244.9

0.66

(3027135) IgG subclass 1 [Mass/volume] in Serum

186

4.02

25.69

1.3

g/l

8.1

6.7

1.28

129

(3028192) IgG subclass 2 [Mass/volume] in Serum

186

4.02

25.69

1.3

g/l

3.2

3.0

0.34

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

186

4.02

25.69

1.3

g/l

0.4

0.27

128

(3012095) Magnesium [Moles/volume] in Serum or Plasma

453

2752

1.80

25.44

5.6

3.6

mmol/l

0.8

1.36

421

2597

(3020779) Urea [Moles/volume] in Serum or Plasma

282

1479

2.03

24.73

11.4

8.0

mmol/l

9.3

8.8

0.53

272

1423

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.30

24.47

4.1

2.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

258

1316

2.08

24.39

5.2

3.5

mmol/l

1.2

0.01

239

1138

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

6.59

24.30

1.6

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

6.59

24.30

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

376

2189

1.85

24.16

9.0

6.1

mmol/l

1.0

0.11

361

2046

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

150

610

2.56

24.15

2.3

2.1

ug/l

10.2

1.7

0.44

137

548

(3033658) Prothrombin time (PT) actual/Normal

661

4520

1.64

23.91

7.4

3.8

95.8

92.5

2.98

645

4412

(3017354) Segmented neutrophils/100 leukocytes in Blood

149

4.25

23.59

3.1

3.4

58.8

53.1

1.00

107

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

321

1803

1.90

22.99

3.2

4.4

u/l

228.0

245.2

1.25

306

1720

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

162

706

2.39

22.47

1.3

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

309

1727

1.91

22.44

1.3

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

680

4750

1.61

22.28

3.7

2.9

e6/l

0.5

0.4

0.24

573

3530

(3007853) Bacteria identified in Skin by Aerobe culture

363

2140

1.82

22.27

1.9

1.7

—

(3018095) Leukocytes [#/volume] in Urine

841

6198

1.56

21.76

4.3

3.5

e6/l

103.6

74.1

0.24

687

4285

(4035726)

269

1452

1.96

21.63

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.03

21.62

1.1

miu/ml

1419.5

1587.7

0.48

(3031040) Bacteria [#/volume] in Urine by Automated count

1425

11789

1.53

21.43

4.9

3.9

e6/l

384.8

1709.5

1.13

152

(3023520) Reticulocytes [#/volume] in Blood

235

1214

2.04

21.38

2.9

e9/l

77.5

71.4

1.22

193

909

(3000850) Epithelial cells [#/volume] in Urine

535

3555

1.65

21.30

3.0

2.5

e6/l

6.2

0.01

492

3119

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

854

6343

1.55

21.19

3.7

3.2

ng/l

46.5

46.6

0.00

547

3893

(3000570) Elastase.pancreatic [Mass/mass] in Stool

116

445

2.69

21.00

1.5

1.4

ug/g

288.4

298.6

0.20

241

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

153

677

2.35

20.50

1.6

2.0

g/l

1.5

0.21

137

598

(3022217) INR in Platelet poor plasma by Coagulation assay

319

1861

1.83

20.14

20.6

20.2

inr

1.3

1.2

0.02

282

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.61

20.03

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

5.68

19.93

1.9

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

127

523

2.51

19.92

5.1

3.9

mg/l

1.4

0.07

116

487

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

411

2590

1.71

19.86

2.2

1.8

—

(40761511) CBC panel - Blood by Automated count

2194

20394

2.20

19.59

24.9

11.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

156

714

2.27

19.31

4.0

2.7

0.7

0.72

151

693

(3016650) Hepatitis A virus Ab [Presence] in Serum

344

2.84

19.21

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

7.96

19.16

3.3

2.9

—

(3052592) Norovirus Ag [Presence] in Stool

10.59

19.12

2.2

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.83

18.85

1.1

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

8.92

18.55

1.9

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

205

1061

2.02

18.50

1.7

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

293

1740

1.78

17.31

3.9

3.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

193

1001

2.01

17.31

6.9

7.2

mmol/l

23.8

24.4

1.61

177

934

(3016502) Oxygen saturation in Arterial blood

278

1631

1.80

17.10

9.0

8.6

96.0

95.9

0.15

261

1577

(3047181) Lactate [Moles/volume] in Blood

120

519

2.38

16.94

6.1

5.8

mmol/l

1.3

0.24

111

453

(3008898) HLA-B27 [Presence]

165

815

2.10

16.88

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

615

4434

1.52

16.68

1.3

u/ml

0.9

1.6

2.45

167

1246

(3003396) Base excess in Arterial blood by calculation

303

1837

1.75

16.64

8.5

8.1

mmol/l

0.9

1.0

0.15

215

1434

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

303

1837

1.75

16.64

8.5

8.1

kpa

4.9

5.1

3.44

283

1759

(3027801) Oxygen [Partial pressure] in Arterial blood

303

1838

1.74

16.60

8.4

8.1

kpa

12.3

12.6

0.47

284

1763

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

162

3.52

16.51

1.1

1.0

mg/l

291.0

287.1

0.13

144

(3019060) Gas panel - Arterial blood

195

1034

1.97

16.41

4.9

5.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

101

410

2.53

16.35

7.1

2.9

mmol/l

24.1

24.8

0.89

366

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.86

16.19

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

114

493

2.38

16.10

4.0

3.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

196

1053

1.94

15.87

5.8

3.6

kpa

5.1

5.2

0.92

185

988

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

410

2724

1.61

15.84

3.3

2.8

e6/l

3.0

2.5

0.58

274

1444

(3019225) pH of Specimen

265

1578

1.77

15.45

4.9

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

595

4332

1.50

15.18

3.2

2.2

—

(3007461) Platelets [#/volume] in Blood

2286

21875

2.88

14.88

41.4

17.5

e9/l

273.3

253.1

33.85

2266

21371

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

420

2.42

14.61

1.8

1.7

—

(1616796) Gas panel - Central venous blood

360

2.53

14.54

4.2

3.7

—

(3024731) MCV [Entitic volume]

2286

21895

2.84

14.47

41.1

17.4

91.2

90.4

13.93

2274

21630

(3035941) MCH [Entitic mass]

2286

21898

2.84

14.41

41.0

17.4

30.3

30.2

1.92

2274

21630

(3009343) pH of Capillary blood

190

1043

1.89

14.41

5.9

3.6

7.4

0.08

129

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

338

2.57

14.39

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

2286

21901

2.83

14.35

41.2

17.4

e12/l

4.5

4.6

23.09

2260

21352

(3011412) CD3 cells [#/volume] in Blood

173

3.23

14.26

1.7

2.5

e9/l

1.2

0.02

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

575

4205

1.49

14.22

1.8

mg/l

1.2

1.0

0.77

445

3117

(3002173) Hemoglobin [Mass/volume] in Arterial blood

254

1530

1.74

14.19

9.6

8.8

g/l

120.7

124.1

1.77

243

1478

(3000963) Hemoglobin [Mass/volume] in Blood

2286

21909

2.82

14.19

41.5

17.5

g/l

134.5

137.7

22.60

2276

21638

(36304419) Bacteria [Presence] in Urine

631

4705

1.47

14.13

3.4

2.9

—

(3020393) Adenovirus Ag [Presence] in Stool

10.06

14.03

1.7

1.1

—

(3010813) Leukocytes [#/volume] in Blood

2285

21908

2.77

13.92

41.4

17.5

e9/l

6.9

6.7

2.71

2258

21360

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

183

1006

1.89

13.82

5.9

3.6

mmol/l

1.3

1.6

0.55

135

744

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

164

871

1.95

13.73

12.2

11.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

418

2884

1.55

13.55

3.1

2.6

e6/l

1.2

1.1

0.22

281

1601

(3000991) Gas panel - Venous blood

232

1381

1.75

13.50

11.4

9.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

165

3.20

13.31

3.9

4.0

—

(3032057) Clostridioides difficile [Presence] in Stool

7.55

12.70

2.2

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

414

2.30

12.35

1.9

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

123

3.46

12.22

1.6

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.15

12.21

1.1

1.3

—

(3000494) Fungus identified in Specimen by Culture

327

2184

1.58

12.15

1.6

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1551

13731

1.38

11.94

5.7

3.0

u/l

61.3

45.2

9.47

1486

13004

(3026389) Candida sp identified in Specimen by Organism specific culture

222

2.75

11.76

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

103

489

2.16

11.72

3.3

u/ml

0.3

0.4

1.08

267

(3015377) Calcium [Moles/volume] in Serum or Plasma

711

5604

1.39

11.20

4.3

3.3

mmol/l

2.3

2.4

5.47

633

4996

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

114

576

2.03

11.03

1.5

1.6

g/l

1.2

0.17

102

545

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.99

10.76

3.8

3.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

110

554

2.03

10.74

1.5

1.6

g/l

0.2

1.68

525

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

274

2.45

10.30

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

457

2.10

10.10

1.2

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

238

2.52

9.79

1.6

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

269

1802

1.56

9.79

2.0

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.92

9.79

1.1

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

266

1778

1.56

9.78

1.9

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

378

2.18

9.67

4.3

3.2

umol/l

30.1

36.4

1.53

333

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

141

800

1.81

9.66

5.9

4.0

mmol/l

24.0

24.1

0.24

132

732

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

111

583

1.95

9.66

2.0

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

284

2.36

9.54

2.6

2.3

umol/l

21.2

5.9

1.67

204

(40767503) Oxygen content in Capillary blood by calculation

350

2.21

9.38

3.5

2.5

16.4

16.6

0.24

171

(3018677) aPTT in Platelet poor plasma by Coagulation assay

364

2622

1.46

9.34

2.2

2.3

29.2

29.7

1.05

350

2544

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

506

2.00

9.32

2.8

2.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

131

3.01

9.16

1.5

2.1

14.3

13.7

0.07

(3027315) Oxygen [Partial pressure] in Blood

381

2.14

9.10

4.4

4.2

kpa

9.0

8.9

0.28

375

(3012501) Base excess in Blood by calculation

381

2.14

9.10

4.4

4.2

mmol/l

2.2

2.4

0.33

248

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

297

2.29

9.07

2.1

1.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

382

2.13

9.04

4.4

4.2

kpa

5.0

0.36

377

(3014111) Lactate [Moles/volume] in Serum or Plasma

224

1471

1.58

8.89

9.2

7.7

mmol/l

1.3

1.4

0.50

212

1410

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

186

1170

1.64

8.81

4.8

4.1

ng/l

88.2

84.8

0.14

164

1056

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

638

5102

1.34

8.77

2.3

2.1

u/l

295.1

242.1

0.18

607

4829

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

296

2.27

8.71

1.7

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

382

2.11

8.66

7.8

3.2

kpa

8.8

8.4

1.08

356

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

163

996

1.68

8.64

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

2.82

8.60

1.3

—

(3021901) Oxygen saturation in Capillary blood

287

2.26

8.45

6.9

2.6

—

(3028433) Virus identified in Specimen by Culture

3.90

8.42

1.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

415

3118

1.40

8.38

1.3

u/ml

7.9

10.9

0.54

158

1301

(3005322) IgE [Units/volume] in Serum or Plasma

201

1309

1.59

8.27

1.4

1.3

u/ml

224.1

213.0

0.06

186

1219

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

522

4082

1.36

8.24

2.8

3.0

ng/l

1546.0

1092.9

0.95

438

3421

(21494815) CD4 cells/100 lymphocytes in Specimen

157

2.71

8.16

1.5

2.3

41.6

44.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

135

2.84

8.12

2.0

2.5

e6/l

436.6

572.3

0.82

118

(3042733) HLA Ab [Presence] in Serum

3.49

8.09

1.6

4.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

117

663

1.80

8.09

2.4

1.9

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

9.13

8.09

1.3

1.1

—

(3019150) Specific gravity of Urine by Refractometry

502

3918

1.36

8.00

4.6

3.6

kg/l

1.0

0.00

107

542

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

348

2.10

7.93

1.7

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

289

2.21

7.91

4.4

3.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

139

834

1.71

7.89

1.9

2.0

u/l

39.9

40.0

0.01

124

758

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

132

2.83

7.86

2.0

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

363

2.07

7.84

3.6

2.3

g/l

125.8

131.8

1.40

266

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

104

574

1.85

7.84

2.7

2.9

g/l

3.3

3.5

0.73

542

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

317

2.15

7.79

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

1963

18463

1.39

7.79

26.2

12.7

38.3

40.6

15.43

1402

14396

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

414

3171

1.37

7.38

3.7

3.4

ng/l

260.4

490.0

1.66

265

2216

(21494814) CD8 cells/100 lymphocytes in Specimen

3.75

7.35

1.2

2.1

—

(3010421) pH of Blood

450

1.92

7.30

4.4

4.0

7.4

0.61

376

(3018405) Lactate [Moles/volume] in Arterial blood

102

574

1.81

7.25

3.9

4.3

mmol/l

1.4

0.06

566

(3022621) pH of Urine by Test strip

174

1135

1.58

7.12

4.3

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

186

1234

1.55

7.07

2.1

2.7

g/l

67.2

66.9

0.17

179

1140

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

200

2.38

7.05

2.0

2.3

31.4

32.3

0.58

200

(3051651) Icteric interference index of Serum or Plasma

114

2.83

6.85

6.3

3.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1561

14310

1.27

6.80

3.2

3.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

104

601

1.76

6.78

2.1

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

132

2.68

6.74

1.6

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

488

1.83

6.59

1.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

422

3305

1.34

6.46

1.3

iu/ml

17.2

29.6

3.32

138

1021

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

186

2.34

6.26

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

132

2.60

6.21

2.0

2.6

e9/l

0.2

0.10

118

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

150

2.49

6.19

2.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

150

2.49

6.19

2.1

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

150

2.49

6.19

2.1

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

121

2.67

6.16

1.2

1.1

—

(3002256) Pathology report gross observation

302

2261

1.39

6.15

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

514

1.78

6.14

2.0

2.2

mg/l

10.8

10.5

0.10

478

(3003694) ABO and Rh group [Type] in Blood

676

5677

1.27

6.07

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.03

6.07

2.2

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

243

2.12

5.91

2.0

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

406

1.85

5.77

1.5

2.4

nmol/l

0.9

0.8

0.37

351

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

564

1.71

5.69

1.1

u/ml

0.7

3.9

—

(3003181) Sodium [Moles/volume] in Urine

247

2.09

5.68

2.0

1.4

mmol/l

68.7

66.1

0.11

207

(40760888) Immunoglobulin light chains.free panel - Serum

311

1.95

5.56

2.0

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

172

1186

1.49

5.50

3.4

2.8

ng/l

283.1

169.6

1.40

159

1062

(3004588) Protein electrophoresis panel - Serum or Plasma

149

999

1.52

5.45

1.8

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

453

1.77

5.36

1.3

1.4

—

(3022313) Gas panel - Capillary blood

120

772

1.58

5.28

6.5

3.7

—

(3037121) Protein [Mass/volume] in Urine

600

1.66

5.26

3.0

3.3

g/l

0.2

0.3

0.22

271

(40768443) Skin Pathology biopsy report

112

710

1.61

5.24

1.3

1.2

—

(44806118)

215

2.11

5.22

1.5

1.6

—

(44790047)

215

2.11

5.22

1.5

1.6

—

(44790048)

215

2.11

5.22

1.5

1.6

—

(44790049)

215

2.11

5.22

1.5

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

126

2.48

5.21

2.8

2.2

u/field

1.8

2.1

0.17

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

143

961

1.52

5.19

2.1

2.3

u/l

5120.0

4686.8

0.05

377

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

518

4287

1.27

5.15

1.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

484

1.72

5.05

4.2

4.5

mmol/l

3.9

0.17

452

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

129

2.42

4.97

2.0

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

555

4652

1.25

4.92

3.0

2.5

umol/l

6986.6

4258.2

0.66

506

4112

(3024471) HLA-A [Type]

2.87

4.92

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

400

1.77

4.84

1.3

1.2

u/ml

46.0

41.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.08

4.79

2.2

3.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

164

2.21

4.72

2.9

1.5

g/l

0.9

1.0

1.17

164

(3051611) Lipemic interference index of Serum or Plasma

158

2.23

4.69

6.2

3.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

191

2.11

4.68

1.9

1.8

—

(3042631) Mycobacterium sp identified in Specimen

192

2.10

4.62

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

199

2.08

4.60

2.0

1.7

—

(3024932) HLA-DR beta [Type]

2.82

4.55

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

323

2561

1.30

4.47

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

582

4955

1.23

4.43

4.7

4.1

mg/mmol

8.1

9.4

0.36

405

3215

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.02

4.40

1.3

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

195

1438

1.39

4.38

4.8

2.4

ml/min/173m2

63.7

72.4

2.96

532

(21494755) Public health laboratory ask at order entry panel

198

2625

0.73

4.26

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

424

1.70

4.25

1.9

3.6

mg/l

37.5

51.8

0.46

336

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

249

1.91

4.17

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

382

1.72

4.13

1.2

u/ml

10.7

4.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1.89

4.08

1.7

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

266

1.86

4.05

2.3

2.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

416

1.68

4.00

1.9

3.6

ratio

1.3

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

424

1.67

3.99

2.0

3.7

mg/l

54.5

68.1

0.37

336

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

549

1.59

3.98

1.3

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

549

1.59

3.98

1.3

2.3

g/l

4.0

3.8

1.00

404

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

549

1.59

3.98

1.3

2.3

g/l

7.4

7.3

0.21

423

(3006270) Folate [Moles/volume] in Blood

138

2.19

3.89

1.2

1.1

nmol/l

344.2

399.0

0.84

129

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

179

2.03

3.84

2.2

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

391

1.68

3.82

1.9

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

112

766

1.49

3.81

1.4

1.3

miu/ml

197.9

219.3

0.22

374

(3004616) Nuclear Ab [Presence] in Serum

222

1.91

3.78

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

488

1.60

3.70

1.3

1.2

u/ml

5.7

7.1

0.20

(3003740) Influenza virus B Ag [Presence] in Specimen

403

1.66

3.68

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

481

1.60

3.67

1.3

1.2

u/ml

7.7

2.5

—

(40761535) Cells panel - Urine sediment

182

1369

1.36

3.65

3.5

3.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.87

3.63

1.3

1.4

ug/l

12.7

8.8

0.93

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.80

3.56

1.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1557

14681

1.18

3.51

3.9

3.8

pmol/l

14.7

14.6

0.91

1446

13555

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

386

1.65

3.48

1.2

—

10.9

—

(3003338) MCHC [Mass/volume]

1802

17214

1.20

3.48

32.2

15.0

g/l

332.1

333.5

7.86

1793

17080

(3000060) B lymphocytes [#/volume] in Blood

2.90

3.46

1.5

2.2

e6/l

234.0

178.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

404

1.63

3.40

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

7.02

3.36

1.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

140

1024

1.39

3.36

12.5

10.5

0.7

0.16

135

1019

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

140

1028

1.38

3.28

12.0

10.3

1.3

1.4

1.18

135

1023

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.59

3.26

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.79

3.25

1.1

—

(3004451) EKG impression Narrative

2.45

3.21

1.7

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.17

3.21

1.1

105.3

95.1

0.91

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.17

3.21

1.2

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.17

3.21

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.51

3.21

1.0

6.1

mg/l

12909.5

77.5

0.47

(3004775) Volume in Urine collected for unspecified duration

137

2.06

3.16

2.5

2.4

726.9

625.1

0.33

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

508

1.53

3.16

1.4

2.4

g/l

10.7

10.3

0.28

437

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

574

1.50

3.13

2.4

2.8

199.8

175.1

1.92

551

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

180

1.90

3.10

1.8

1.6

44.4

57.5

0.88

116

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

325

1.65

2.97

1.1

iu/ml

67.6

1615.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

561

0.55

2.90

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

149

1.96

2.90

2.0

2.6

e6/l

752.6

768.2

0.03

(3024891) Influenza virus A+B Ag [Presence] in Specimen

560

1.48

2.89

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.44

2.88

2.5

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.44

2.88

2.5

2.0

—

(3005033) Fetal Nuchal fold Thickness US

558

0.55

2.86

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.94

2.86

1.1

—

(3020891) Body temperature

628

1.45

2.85

6.6

4.9

—

(3017704) Immunofixation for Urine

2.30

2.84

1.7

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

186

1.84

2.83

2.4

6.5

mmol/l

6.3

7.2

0.90

155

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.20

2.83

1.0

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.40

2.80

2.5

2.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

677

0.60

2.76

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.32

2.74

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

676

0.60

2.74

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

112

1510

0.73

2.74

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

674

0.60

2.71

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

160

1.89

2.71

1.3

u/ml

0.4

0.6

0.31

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

115

847

1.38

2.70

13.5

11.1

mmol/l

23.4

24.3

1.95

108

804

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

672

0.60

2.68

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1818

17499

1.17

2.67

4.7

4.5

mu/l

1.7

2.1

1.81

1702

16274

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.76

2.67

2.0

1.2

—

(3012516) Albumin [Mass/volume] in Urine

537

4737

1.17

2.66

3.4

3.3

mg/l

470.1

332.3

0.28

362

3077

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

637

1.43

2.66

2.0

2.5

87.8

93.0

1.23

597

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

119

2.03

2.66

1.0

1.5

u/l

4.8

6.4

1.36

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.13

2.64

1.7

1.6

—

(3000012) Reticulocyte production index

2.31

2.58

1.1

1.8

—

(3015183) Erythrocyte sedimentation rate

128

1.96

2.55

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

575

0.59

2.53

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.20

2.47

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

883

0.67

2.44

1.4

1.7

mg/l

3.1

4.2

0.67

616

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

282

3328

0.83

2.36

2.9

2.8

ug/l

0.7

0.28

197

2028

(3044889) 12 lead EKG panel

1344

12714

1.13

2.36

3.7

3.4

—

(3006653) Thiamine [Moles/volume] in Blood

105

2.01

2.30

1.2

1.4

nmol/l

145.3

138.1

0.23

105

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.22

2.30

2.0

2.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

1.97

2.30

2.0

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

573

1.41

2.26

2.0

2.4

ug/l

307.1

300.7

0.02

540

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.16

2.24

1.1

—

(3025130) Human papilloma virus identified in Specimen

287

1.58

2.23

2.2

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

240

1.64

2.23

1.7

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

118

903

1.32

2.21

1.5

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.05

2.21

1.7

3.1

u/ml

864.7

1224.9

0.45

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.56

2.21

1.0

5.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

107

1.97

2.20

1.3

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

460

4072

1.16

2.16

3.9

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

343

2966

1.18

2.16

1.8

1.9

1.4

1.35

290

2662

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

741

0.67

2.15

1.4

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

182

2222

0.80

2.14

1.6

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

189

1.70

2.13

2.7

2.1

mg/l

19.0

23.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.21

2.09

1.5

3.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.01

2.07

1.4

3.4

—

(4038314)

3.51

2.05

1.1

1.2

—

(21494434) Karyotype in Bone marrow

147

1.78

2.02

1.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

289

1.53

1.95

1.8

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

437

1.43

1.95

1.4

—

(3011985) Renin [Units/volume] in Plasma

210

1.63

1.95

1.8

1.4

mu/l

119.2

37.2

1.35

187

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.19

1.94

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.55

1.94

1.0

1.4

u/l

3.8

13.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

142

1.77

1.93

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

2.12

1.92

1.6

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

212

1.61

1.88

1.0

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

595

5417

1.13

1.85

3.4

3.3

mmol/l

8.4

8.1

0.90

510

4639

(36660697) Celiac disease serology panel - Serum

187

1553

1.22

1.84

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.17

1.82

1.0

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

327

1.48

1.82

1.3

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.96

1.79

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

366

3240

1.15

1.73

1.7

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.92

1.72

1.3

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.88

1.70

2.2

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

141

1.71

1.68

1.2

1.1

—

86.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

103

1300

0.78

1.66

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

404

4502

0.88

1.66

4.0

3.8

19.4

21.3

1.87

199

1935

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

326

1.45

1.65

1.0

u/ml

0.9

2.4

3.24

160

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

150

1.67

1.63

1.9

1.4

40.6

34.6

0.31

(3023419) Bacteria identified in Sputum by Culture

213

1.56

1.62

3.8

2.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.33

1.60

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1237

0.78

1.60

1.2

—

(4010399)

148

1221

1.23

1.59

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

152

1.65

1.56

6.0

3.0

mg/l

41.6

39.4

0.03

115

(3051387) C reactive protein [Mass/volume] in Capillary blood

381

1.40

1.55

3.8

3.7

mg/l

21.4

24.3

0.39

240

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.98

1.54

2.1

2.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

838

0.74

1.52

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

1.52

1.0

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

138

1.67

1.51

1.1

—

33.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

209

1.54

1.51

1.1

1.3

nmol/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

126

0.40

1.49

1.4

1.3

nmol/l

45.1

31.7

—

106

(3045414) Leukocytes [Presence] in Urine

100

797

1.27

1.47

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

140

1.65

1.45

1.1

1.2

—

61.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

102

1.77

1.44

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

319

1.42

1.44

1.5

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.13

1.44

1.0

—

(3045424) Erythrocytes [Presence] in Urine

311

1.42

1.43

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

154

0.45

1.42

1.7

3.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

134

1.65

1.39

1.0

1.1

u/ml

0.9

2.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.78

1.39

2.2

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

520

1.32

1.38

1.3

2.4

g/l

3.1

0.19

412

(3027456) Digoxin [Moles/volume] in Serum or Plasma

239

1.47

1.37

2.2

3.1

nmol/l

0.8

0.54

183

(3048879) Bone marrow aspiration report

2.20

1.37

2.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.61

1.36

1.0

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

320

2859

1.14

1.35

3.4

2.8

mmol/l

2.4

0.88

270

2527

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

1.34

0.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

1.34

0.0

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1.85

1.29

1.9

3.2

umol/l

98.7

110.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.36

1.29

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

177

1.53

1.29

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

146

1.58

1.26

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.91

1.22

1.0

1.1

u/ml

0.5

1.7

—

(3036489) Thrombin time

727

1.25

1.22

2.1

2.3

22.4

21.3

0.50

640

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

159

1360

1.18

1.22

2.3

2.4

au/ml

7.3

22.9

—

101

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.97

1.22

1.4

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

107

1288

0.82

1.19

1.4

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

427

0.70

1.16

1.4

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.05

1.15

19.4

5.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.14

0.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

155

1796

0.85

1.13

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.90

1.12

2.5

2.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

137

0.51

1.09

1.3

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

295

1.36

1.08

1.7

1.9

—

1018.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

244

1.40

1.07

1.1

1.3

nmol/l

—

0.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

313

1.35

1.06

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

944

0.81

1.05

1.7

1.6

mu/l

320.6

287.2

0.34

859

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

570

1.25

1.05

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

597

1.25

1.05

1.5

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

103

861

1.21

1.05

2.4

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.96

1.03

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.28

1.03

2.0

2.6

—

(3051593) INR in Capillary blood by Coagulation assay

1.84

1.02

16.5

14.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

727

1.22

1.01

1.4

u/l

8.8

8.4

0.08

602

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.89

1.01

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.89

1.01

1.3

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

155

1.49

1.01

1.4

2.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

147

1.50

1.00

2.5

1.4

—

65.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

710

1.22

1.00

1.7

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.00

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.00

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

232

2585

0.89

0.99

1.6

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

231

2069

1.13

0.98

3.9

4.0

32.6

31.4

0.92

185

1474

(3011288) Drugs identified in Urine by Screen method

826

0.81

0.98

1.5

3.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.18

0.98

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.18

0.98

2.2

1.5

ng/l

120.0

108.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

0.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

224

1.39

0.96

1.1

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.77

0.94

4.4

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.77

0.94

4.4

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

131

1132

1.17

0.94

1.4

iu/l

28.0

24.5

0.56

121

953

(3028707) Methadone [Presence] in Urine by Screen method

531

0.77

0.91

1.4

3.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

126

1.51

0.91

1.9

2.9

35.5

43.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

1.49

0.89

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.79

0.87

1.1

—

(40765096) Chromosome analysis panel by Banding

1.79

0.87

1.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

203

1.38

0.87

1.8

1.4

pmol/l

510.0

293.3

0.60

160

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.00

0.87

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

396

1.27

0.86

1.7

e6/l

9942.5

14559.6

0.55

292

(3022689) Creatine [Moles/volume] in Urine

1.82

0.86

2.6

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

0.85

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.94

0.84

1.3

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1906

19347

0.92

0.84

4.6

4.3

mmol/l

2.7

2.8

4.88

1786

18102

(3023410) Appearance of Cerebral spinal fluid

215

0.65

0.84

2.1

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

929

0.83

0.84

1.3

2.4

—

(3016879) Cocaine [Presence] in Urine

1111

0.85

0.83

1.3

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

545

0.79

0.83

2.0

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

472

1.23

0.81

1.3

2.6

g/l

1.0

0.01

421

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

189

1.38

0.81

2.2

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

124

1415

0.87

0.80

1.8

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

233

1.33

0.79

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.79

0.0

1.2

—

(40757373) Influenza virus identified in Isolate

1.82

0.79

1.3

2.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

140

1.43

0.77

3.2

2.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.76

0.0

1.1

—

(3012565) Volume of 24 hour Urine

1.54

0.75

2.2

2.7

1815.7

2177.0

0.75

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.64

0.75

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

116

1.47

0.74

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

150

1.40

0.73

1.1

—

(44806420)

1.80

0.72

2.1

2.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.55

0.72

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

137

1217

1.13

0.71

3.6

3.4

pmol/l

4.4

4.6

1.26

122

1091

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

147

1312

1.13

0.71

2.6

2.2

ug/l

5.3

7.6

1.14

137

1188

(3008536) Aspergillus sp Ab [Presence] in Serum

1.75

0.71

3.0

1.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.93

0.70

1.6

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.93

0.70

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.71

0.70

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.55

0.69

5.8

4.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

143

0.63

0.69

1.6

1.3

—

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

409

1.23

0.69

2.8

2.5

ug/min

47.1

135.6

2.38

263

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

310

1.26

0.69

1.4

1.6

—

(40768446) Kidney Pathology biopsy report

1.53

0.69

2.2

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.53

0.68

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.79

0.66

1.6

1.2

—

(3027944) Amphetamines [Presence] in Urine

103

1169

0.88

0.65

1.2

2.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.59

0.65

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.59

0.65

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.59

0.65

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.59

0.65

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.73

0.64

7.4

7.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.59

0.61

2.6

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

105

1184

0.88

0.61

1.2

2.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.60

0.0

1.0

—

9.1

—

(4024509)

139

1.37

0.60

1.3

1.4

—

(4034850)

611

1.17

0.60

13.3

8.5

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.59

0.0

1.2

—

(3035880) pH of Pleural fluid

1.53

0.59

1.1

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

201

1.30

0.59

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.58

0.0

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.46

0.58

1.2

1.1

iu/ml

153.7

184.7

0.29

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

283

1.24

0.56

1.3

1.4

mmol/l

7.4

7.2

0.13

205

(3028300) Cannabinoids [Presence] in Urine

107

1197

0.89

0.56

1.3

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.58

0.56

1.0

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1689

17138

0.95

0.55

6.2

5.0

mmol/mol

39.9

39.0

2.89

1589

16098

(40768800) Prostate Pathology biopsy report

307

0.78

0.55

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

186

1.29

0.54

1.3

1.4

mmol/l

11.1

12.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.47

0.54

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.54

1.3

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.53

1.2

1.1

—

(44813793)

134

1.35

0.53

1.1

1.0

—

(3027008) Opiates [Presence] in Urine

107

1191

0.89

0.53

1.3

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

152

1.32

0.52

1.2

1.3

e6/l

45696.0

87665.7

0.40

103

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.50

0.51

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.50

0.51

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

135

0.67

0.51

1.6

1.9

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

510

0.84

0.51

2.4

2.0

iu/l

3.7

4.7

0.50

190

(3021788) Differential panel - Synovial fluid

297

1.22

0.50

1.8

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.46

0.50

7.5

6.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

476

0.84

0.49

1.4

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

464

4847

0.95

0.49

1.9

1.6

mmol/l

1.5

1.4

0.45

399

4156

(4015189)

1.56

0.49

1.9

2.8

—

(3044007) Cell count panel - Peritoneal fluid

1.52

0.48

1.7

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1879

18988

0.95

0.48

4.3

4.0

mmol/l

1.4

0.38

1763

17804

(4211845)

1.43

0.45

4.4

2.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.59

0.45

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

112

1.34

0.44

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.41

0.43

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

131

0.69

0.43

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

0.78

0.42

1.2

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.56

0.42

1.0

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.40

0.42

1.4

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

149

1.28

0.41

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

16.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

772

0.89

0.40

1.9

1.8

nmol/l

38.5

38.3

0.02

751

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.43

0.39

1.0

1.2

—

226.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.39

0.0

2.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

196

1.23

0.39

1.2

1.4

pmol/l

100.2

75.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

148

0.74

0.38

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

258

0.81

0.38

5.2

3.7

u/ml

17.3

29.7

1.40

253

(3006462) Nitrate [Presence] in Urine

1.34

0.38

3.9

2.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.35

0.37

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

549

5667

0.96

0.37

4.6

4.3

ug/l

3.9

2.2

0.56

504

5109

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

146

0.75

0.36

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

0.75

0.36

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

146

0.75

0.36

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

146

0.75

0.36

1.1

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.31

0.35

2.4

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1815

18315

0.96

0.35

4.0

3.6

mmol/l

1.3

0.69

1702

17107

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

320

1.16

0.34

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

191

1.21

0.33

1.5

1.6

mmol/l

7.1

7.5

0.46

118

(3044290) Cell count panel - Cerebral spinal fluid

425

1.13

0.33

1.7

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.76

0.33

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

144

0.76

0.33

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

144

0.76

0.33

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.31

0.33

2.0

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

296

0.84

0.33

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

445

0.87

0.33

1.2

1.1

u/ml

0.6

2.4

—

115

(3024928) Oxygen saturation in Venous blood

361

1.14

0.31

5.3

2.7

—

(4133840)

1.25

0.29

1.4

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

222

2322

0.95

0.28

1.5

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

317

1.14

0.28

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

112

1.25

0.28

1.4

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

468

0.90

0.26

1.1

u/ml

9.2

5.8

0.42

255

(3014133) Dog dander IgE Ab [Units/volume] in Serum

377

1.12

0.25

1.1

u/ml

1.2

3.6

2.18

151

(4146454)

160

1.19

0.25

2.0

2.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

435

1.11

0.25

1.2

2.4

g/l

38.9

38.1

0.43

380

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.24

0.24

1.2

1.1

—

(3000492) Spirometry study

210

2017

1.05

0.23

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

310

3200

0.96

0.23

1.9

2.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.32

0.23

7.4

6.3

—

(4198724)

125

0.80

0.23

1.6

3.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

153

1.18

0.22

2.9

4.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

1.7

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

156

0.83

0.21

1.1

1.8

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

799

1.07

0.21

2.4

2.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

1.20

0.20

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

164

1.16

0.20

1.3

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.1

—

0.2

—

(4212803)

0.00

0.20

0.0

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

707

0.93

0.20

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.22

0.19

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.22

0.19

1.3

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

280

2879

0.97

0.18

1.8

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

321

0.90

0.18

1.1

1.6

—

(3036603) Volume of Urine

119

1.18

0.17

2.1

1.5

1634.0

1947.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.13

0.17

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

444

0.92

0.17

1.1

u/ml

0.2

1.6

2.17

189

(3014271) Vancomycin [Susceptibility]

1.11

0.17

2.1

2.4

—

(4027681)

148

1.15

0.17

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

215

0.88

0.16

1.9

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.16

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

152

1465

1.04

0.16

1.2

iu/ml

102.6

141.0

0.64

559

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

246

0.89

0.16

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.13

0.16

1.6

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

130

1.15

0.15

1.7

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

161

0.87

0.15

1.1

—

(3024263) Appearance of Synovial fluid

0.79

0.14

3.6

1.7

—

(4094501)

481

0.93

0.14

1.1

—

(3045788) Cell count panel - Pleural fluid

118

0.85

0.14

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

100

0.80

0.13

1.7

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

159

0.88

0.13

1.4

1.5

—

(3045142) Bone marrow Pathology biopsy report

180

1.11

0.13

1.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

335

1.08

0.13

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

335

1.08

0.13

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

110

0.82

0.13

1.6

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1903

19091

0.98

0.11

4.4

4.0

mmol/l

4.6

4.7

2.86

1794

17992

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

339

1.06

0.10

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

262

1.07

0.09

1.4

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

208

2042

1.02

0.09

8.3

6.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.09

0.09

1.0

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

439

1.05

0.09

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

341

1.06

0.08

1.2

u/ml

7.5

3.6

0.56

115

(3029396) Erythrocyte agglutination [Presence] in Blood

1.03

0.08

2.2

3.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

123

0.89

0.08

1.0

1.1

—

4.8

—

(3047189) Immunofixation for 24 hour Urine

0.84

0.07

1.5

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

757

1.03

0.07

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.08

0.07

1.1

—

0.0

—

(3012441) Differential panel - Pleural fluid

137

1.10

0.07

1.3

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

186

1.08

0.07

1.2

mg/l

35.3

43.8

0.51

153

(3023511) Choriogonadotropin [Units/volume] in Urine

538

0.97

0.06

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

112

1097

1.02

0.06

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

141

0.92

0.05

1.2

1.5

—

(3020491) Glucose [Moles/volume] in Blood

149

1.07

0.05

1.4

2.0

mmol/l

7.4

6.6

—

102

(3038177) Helicobacter pylori Ab [Presence] in Serum

364

0.96

0.05

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

287

1.05

0.05

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

170

1722

0.99

0.05

2.5

2.2

nmol/l

12.6

13.2

0.46

156

1562

(3014051) Protein [Presence] in Urine by Test strip

387

1.03

0.04

2.2

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

704

0.98

0.04

1.9

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

210

0.95

0.03

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

379

1.03

0.03

1.3

1.5

nmol/l

0.4

0.11

301

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

189

0.95

0.03

4.7

4.9

u/ml

12.6

91.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

350

0.97

0.03

1.1

u/ml

2.5

5.1

1.16

146

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

178

0.95

0.02

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

117

0.94

0.01

6.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

332

1.02

0.01

1.2

1.3

u/ml

6.2

5.1

0.23

152

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

498

0.98

0.01

1.2

1.1

u/ml

2.0

1.5

0.09

208

(1761868) Lipid panel - Serum or Plasma

766

7648

1.00

0.01

3.3

2.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

453

1.02

0.01

1.6

1.4

e6/l

53.4

23.1

0.38

354

(4306422)

334

1.02

0.00

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

135

0.96

0.00

1.1

—

4.0

—

(40768793) Breast Pathology biopsy report

389

1.00

0.00

1.2

—

(1002224) Polysomnography panel

995

0.99

0.00

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

609

1.00

0.00

1.4

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

116

1.03

0.00

1.4

1.1

—

(4281824)

168

1.01

0.00

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1827

18266

1.00

0.00

4.2

4.0

mmol/l

5.9

0.68

1695

16915

(3044941) Cell count panel - Synovial fluid

267

1.01

0.00

1.3

1.4

—

(3049717) Cytology report of Urine Cyto stain

573

0.99

0.00

2.8

2.6

—

(4268621)

233

0.99

0.00

2.2

2.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1500.8

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.0

—

1067.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.91

0.00

1.6

2.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

118.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.86

0.00

1.2

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.00

0.00

1.2

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.02

0.00

1.2

40.0

51.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

205.7

—

(3017569) Oxygen content in Arterial blood

0.89

0.00

1.6

2.7

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3034426) Prothrombin time (PT)

0.90

0.00

1.4

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint ULCEROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
ULCEROTH	1.372 [1.22, 1.55]	< 0.001
Birth year	1.001 [0.99, 1.01]	0.903

During the follow-up period (1.1.1998 — 31.12.2019), 567 out of 5349 females with ULCEROTH died.

Males

Parameter	HR [95% CI]	p-value
ULCEROTH	1.247 [1.12, 1.39]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 815 out of 5965 males with ULCEROTH died.

Mortality risk

Mortality risk for people of age

years, who have ULCEROTH.

N-year risk	Females	Males
1	0.097%	0.224%
5	0.749%	1.434%
10	2.112%	3.919%
15	4.287%	7.111%
20	7.497%	12.132%

Relationships between endpoints

↥

Index endpoint: ULCEROTH – Other ulcerative colitis

GWS hits: 12

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other ulcerative colitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints